# Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/par-24-129-limited-competition-specific-pathogen-free-macaque-colonies/  
Official notice: https://www.grants.gov/search-results-detail/351920

> National Institutes of Health offered grants to colleges and universities. Applications closed on September 25, 2026.

| Field | Value |
|---|---|
| Opportunity number | PAR-24-129 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | September 25, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.310, 93.351 |

## Who can apply

- Public and State controlled institutions of higher education

Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. see NOFO for eligibility details

## What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-18-669 that support Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) research. Breeding colonies are essential to sustain appropriate SPF macaques for research related to HIV/AIDS. Pedigree SPF macaques are free of certain viruses, which may confound the results of HIV/AIDS-related investigations or present a risk to the personnel who care for the animals. The SPF macaques are genetically characterized for major histocompatibility complex (MHC) class I types, because MHC class I genotypes have large effects on macaque immune responses to Simian Immunodeficiency Virus (SIV) that can induce AIDS in nonhuman primates (NHPs) and on human immune responses to HIV.

## Questions people ask

### Is PAR-24-129 still open?

No. It closed on September 25, 2026.

### Who can apply for Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)?

Closed September 25, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-24-129?

NIH RePORTER lists 5 projects funded under PAR-24-129 in fiscal 2024 to 2026, at 4 institutions. The most were at Tulane University of Louisiana, Emory University, Johns Hopkins University.

### Who has won Trans-NIH Research Support grants before?

The largest recipients over five fiscal years were Duke University, The Leland Stanford Junior University, University of Pittsburgh - of the Commonwealth System of Higher Education. The program made 4,433 awards worth $5.9 billion in that time.